Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $99.30
- Average 1Y price target
- $104.40+5.14%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF2
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $126.00 |
| Last quarter | 6 | $98.83 |
| Last year | 12 | $78.00 |
| All time | 25 | $49.68 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 28, 2026 | UBS | maintain | Buy | Buy |
| Sep 28, 2026 | LifeSci Capital | maintain | Outperform | Outperform |
| Sep 28, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 17, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 3, 2026 | JP Morgan | maintain | Overweight | Overweight |
| May 11, 2026 | Chardan Capital | upgrade | Neutral | Buy |
| Mar 27, 2026 | UBS | maintain | Buy | Buy |
| Mar 27, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 10, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jan 22, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 17, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 17, 2025 | Chardan Capital | maintain | Neutral | Neutral |
| Nov 11, 2025 | HC Wainwright & Co. | upgrade | Neutral | Buy |
| Oct 24, 2025 | JP Morgan | upgrade | Neutral | Overweight |
| Oct 6, 2025 | Chardan Capital | maintain | Neutral | Neutral |
| Sep 25, 2025 | Barclays | upgrade | Underweight | Equal Weight |
| Aug 18, 2025 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Aug 14, 2025 | JP Morgan | upgrade | Underweight | Neutral |
| Aug 14, 2025 | Barclays | maintain | Underweight | Underweight |
| Mar 31, 2025 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Dec 9, 2024 | Jefferies | upgrade | Hold | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Nov 15, 2024 | Barclays | maintain | Underweight | Underweight |
| Sep 24, 2024 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Apr 4, 2024 | UBS | maintain | Neutral | Neutral |
| Apr 1, 2024 | Barclays | maintain | Underweight | Underweight |
| Dec 21, 2023 | UBS | maintain | Neutral | Neutral |
| Nov 17, 2023 | Capital One | upgrade | Equal Weight | Overweight |
| Jul 27, 2023 | UBS | downgrade | Buy | Neutral |
| Jul 25, 2023 | JP Morgan | downgrade | Neutral | Underweight |
| Jul 25, 2023 | Chardan Capital | downgrade | Buy | Neutral |
| Jul 25, 2023 | Barclays | maintain | Underweight | Underweight |
| Jul 24, 2023 | Jefferies | downgrade | Buy | Hold |
| Jul 24, 2023 | Capital One | downgrade | Overweight | Equal Weight |
| Apr 4, 2023 | JP Morgan | maintain | Neutral | Neutral |
| Nov 14, 2022 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Nov 10, 2022 | Goldman Sachs | maintain | Neutral | Neutral |
| Aug 15, 2022 | Morgan Stanley | maintain | Equal Weight | Equal Weight |